548 related articles for article (PubMed ID: 19628189)
1. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?
Rigatelli G; Aggio S; Cardaioli P; Braggion G; Giordan M; Dell'avvocata F; Chinaglia M; Rigatelli G; Roncon L; Chen JP
JACC Cardiovasc Interv; 2009 Jul; 2(7):655-62. PubMed ID: 19628189
[TBL] [Abstract][Full Text] [Related]
2. Incomplete aneurysm coverage after patent foramen ovale closure in patients with huge atrial septal aneurysm: effects on left atrial functional remodeling.
Rigatelli G; Ronco F; Cardaioli P; Dell'avvocata F; Braggion G; Giordan M; Aggio S
J Interv Cardiol; 2010 Aug; 23(4):362-7. PubMed ID: 20718907
[TBL] [Abstract][Full Text] [Related]
3. Left atrial enlargement as a maker of significant high-risk patent foramen ovale.
Rigatelli G; Zuin M; Adami A; Aggio S; Lanza D; d'Elia K; Braggion G; Russo M; Mazza A; Roncon L
Int J Cardiovasc Imaging; 2019 Nov; 35(11):2049-2056. PubMed ID: 31325066
[TBL] [Abstract][Full Text] [Related]
4. Is the hole only a part of the whole?
Block PC
JACC Cardiovasc Interv; 2009 Jul; 2(7):663-4. PubMed ID: 19628190
[No Abstract] [Full Text] [Related]
5. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
[TBL] [Abstract][Full Text] [Related]
6. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.
von Bardeleben RS; Richter C; Otto J; Himmrich L; Schnabel R; Kampmann C; Rupprecht HJ; Marx J; Hommel G; Münzel T; Horstick G
Int J Cardiol; 2009 May; 134(1):33-41. PubMed ID: 18715659
[TBL] [Abstract][Full Text] [Related]
7. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.
Wahl A; Krumsdorf U; Meier B; Sievert H; Ostermayer S; Billinger K; Schwerzmann M; Becker U; Seiler C; Arnold M; Mattle HP; Windecker S
J Am Coll Cardiol; 2005 Feb; 45(3):377-80. PubMed ID: 15680715
[TBL] [Abstract][Full Text] [Related]
9. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
[TBL] [Abstract][Full Text] [Related]
10. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study.
Rigatelli G; Dell'avvocata F; Braggion G; Giordan M; Chinaglia M; Cardaioli P
Catheter Cardiovasc Interv; 2008 Dec; 72(7):973-6. PubMed ID: 19021284
[TBL] [Abstract][Full Text] [Related]
11. Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients.
Ueno Y; Shimada Y; Tanaka R; Miyamoto N; Tanaka Y; Hattori N; Urabe T
Cerebrovasc Dis; 2010; 30(1):15-22. PubMed ID: 20424440
[TBL] [Abstract][Full Text] [Related]
12. Patent foramen ovale and cryptogenic stroke: a matter of age?
Handke M; Harloff A; Bode C; Geibel A
Semin Thromb Hemost; 2009 Jul; 35(5):505-14. PubMed ID: 19739041
[TBL] [Abstract][Full Text] [Related]
13. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm scheduled for transcatheter closure may play a role in aura genesis.
Rigatelli G; Dell'avvocata F; Cardaioli P; Ronco F; Giordan M; Braggion G; Aggio S; Chinaglia M; Cheng JP; Nanjundappa A
J Interv Cardiol; 2010 Aug; 23(4):370-6. PubMed ID: 20624202
[TBL] [Abstract][Full Text] [Related]
14. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
[TBL] [Abstract][Full Text] [Related]
15. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL;
J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162
[TBL] [Abstract][Full Text] [Related]
16. Gore Helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial septal aneurysm: short- and mid-term clinical and echocardiographic outcomes.
Musto C; Cifarelli A; Fiorilli R; De Felice F; Parma A; Pandolfi C; Confessore P; Bernardi L; Violini R
J Invasive Cardiol; 2012 Oct; 24(10):510-4. PubMed ID: 23043034
[TBL] [Abstract][Full Text] [Related]
17. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
Thompson AJ; Hagler DJ; Taggart NW
Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
[TBL] [Abstract][Full Text] [Related]
18. Prominence of the Eustachian valve in paradoxical embolism.
Vale TA; Newton JD; Orchard E; Bhindi R; Wilson N; Ormerod OJ
Eur J Echocardiogr; 2011 Jan; 12(1):33-6. PubMed ID: 20813791
[TBL] [Abstract][Full Text] [Related]
19. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
[TBL] [Abstract][Full Text] [Related]
20. Cardiac and Echocardiographic Markers in Cryptogenic Stroke with Incidental Patent Foramen Ovale.
Tateishi Y; Ueno Y; Tsujino A; Kuriki A; Kamiya Y; Shimizu T; Doijiri R; Yamaguchi E; Kikuno M; Shimada Y; Takekawa H; Koga M; Ihara M; Hirata K; Hasegawa Y; Toyoda K; Hattori N; Urabe T;
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105892. PubMed ID: 34107415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
